logo

For the Inventor, By the Inventor

Huddinge, Sweden

Urszula Grabowska

This inventor holds 18 USPTO granted patents and 3 published patent applications and 2 EPO patents, primarily in Protease Inhibitors. Top assignees: Medivir Ab, Medivir UK Ltd. Active years: 2011-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Urszula Grabowska. Retrieved from https://idiyas.com/inventor/urszula-grabowska

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 18 

% Patents Active = 50.0

 

Average Co-Inventor Count = 5.6

ph-index = 5

Forward Citations = 39(Granted Patents)


Location History:

  • Little Chesterford, GB (2011 - 2012)
  • Essex, GB (2012 - 2017)
  • Huddinge, SE (2013 - 2022)

Company Filing History:

goldMedal14 out of 120 
 
Medivir Ab
 patents
silverMedal4 out of 4 
 
Medivir UK Ltd
 patents

Years Active: 2011-2025

Loading Chart...
Loading Chart...
Areas of Expertise:
Protease Inhibitors
Cysteine Protease Inhibitors
Crystalline Polymorph
Ethynyl Compounds
Thiazole Derivatives
Benzamide Compounds
Pharmaceutical Chemistry
Drug Development
Biochemical Research
Therapeutic Agents
18 patents (USPTO):Explore Patents
1. 12378209 - Protease inhibitors (2025-08-05),
2. 11312693 - Protease inhibitors (2022-04-26),
3. 10723709 - Protease inhibitors (2020-07-28),
4. 10329266 - Protease inhibitors (2019-06-25),
5. 9650388 - Form 2 crystalline polymorph of a salt of N-[1-6-(ethynyl-3-oxo-hexahydro-furo[3,2-B]pyrrole-4-carbonyl)-3-methyl-butyl]-4-[5-fluoro-2-(4-methyl-piperazinyl) thiazol-4-yl]-benzamide useful as cysteine protease inhibitor (2017-05-16),
6. 9428517 - Protease inhibitors (2016-08-30),
7. 9200006 - Protease inhibitors (2015-12-01),
8. 8859605 - Cysteine protease inhibitors (2014-10-14),
9. 8859505 - Cysteine protease inhibitors (2014-10-14),
10. 8853281 - Cysteine protease inhibitors (2014-10-07),
11. 8815809 - Cysteine protease inhibitors (2014-08-26),
12. 8735395 - Protease inhibitors (2014-05-27),
13. 8466158 - Cysteine protease inhibitors (2013-06-18),
14. 8426421 - Protease inhibitors (2013-04-23),
15. 8242119 - Protease inhibitors (2012-08-14),

Title: The Innovative Journey of Urszula Grabowska

Introduction

Urszula Grabowska, a prominent inventor based in Huddinge, Sweden, has made significant contributions to the field of biochemistry with a focus on protease inhibitors. With a remarkable portfolio of 17 patents, Urszula showcases her ingenuity and commitment to innovation in the pharmaceutical sector.

Latest Patents

Among her latest patents are groundbreaking compounds of the formula II, designed as protease inhibitors. These innovations have the potential to advance therapeutic approaches and offer new solutions in treating various diseases, demonstrating her pivotal role in modern medicine.

Career Highlights

Urszula has worked with notable companies such as Medivir AB and Medivir UK Ltd., where she has honed her skills in research and development. Her extensive experience within these organizations has equipped her with the expertise necessary to drive forward-thinking initiatives in drug development.

Collaborations

Throughout her career, Urszula has collaborated with talented professionals, including Pia Kahnberg and Magnus Nilsson. These partnerships have fostered an environment of creativity and scientific advancement, allowing for the successful development of innovative therapies that address critical health issues.

Conclusion

Urszula Grabowska's impressive body of work and her dedication to innovation illustrate the vital role inventors play in shaping the future of healthcare. Her contributions not only enhance our understanding of biochemistry but also pave the way for future discoveries in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…